Treatment of Postnatal Depression for Low-Income Mothers in Primary Care in Santiago, Chile (DPP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A randomized clinical trial was carried out at primary care level in Santiago, Chile to investigate a combined treatment for women suffering post-natal depression and preventing the adverse consequences of this illness on infant's growth and development.
| Condition | Intervention |
|---|---|
|
Postnatal Depression |
Other: multi-component intervention Other: Usual care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Randomized Clinical Trial for the Treatment of Postnatal Depression |
- EPDS [ Time Frame: 3 and 6 months ]
- four dimensions of the Short Form-36 (SF-36) Questionnaire: mental health; emotional role; social functioning; and vitality(34) and significant clinical improvement. [ Time Frame: 3 and 6 months ]
| Enrollment: | 230 |
| Study Start Date: | March 2004 |
| Study Completion Date: | July 2006 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: PND-MCI
The multi-component intervention involved a psychoeducational group, treatment adherence support, and pharmacotherapy if needed
|
Other: multi-component intervention
The PND-MCI included psycho-educational groups, structured pharmacotherapy if needed, and systematic monitoring of clinical progress and treatment compliance
|
|
Active Comparator: usual care
'Usual care' included all services normally available in the clinics, including antidepressant medication, brief psychotherapeutic interventions or referral for specialty treatment
|
Other: Usual care
included all services normally available in the clinics, including antidepressant medication, brief psychotherapeutic interventions or referral for specialty treatment
|
Detailed Description:
Background: We compared the effectiveness of a multi-component intervention with usual care to treat postnatal depression among low-income mothers in primary care clinics in Santiago, Chile.
Methods: Randomised controlled trial. Two hundred and thirty mothers with major depression attending postnatal clinics were randomly allocated to either a multi-component intervention or usual care. The multi-component intervention involved a psychoeducational group, treatment adherence support, and pharmacotherapy if needed. Data were analysed on an intention-to-treat basis. The main outcome measure was the Edinburgh Postnatal Depression Scale (EPDS) at 3 and 6 months after randomisation.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Mothers meeting criteria for current DSM-IV major depression were eligible.
Exclusion Criteria:
- who had received any form of treatment for their depression during their current postnatal period,
- those who were pregnant,
- with psychotic symptoms,
- serious suicidal risk,
- history of mania,
- alcohol or drug abuse
Contacts and Locations
More Information
No publications provided by Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00518830 History of Changes |
| Other Study ID Numbers: | 1040434 |
| Study First Received: | August 20, 2007 |
| Last Updated: | August 20, 2007 |
| Health Authority: | Chile: Comisión Nacional de Investigación Científica y Tecnológica |
Keywords provided by Fondo Nacional de Desarrollo Científico y Tecnológico, Chile:
|
postnatal depression primary care depressed women |
Additional relevant MeSH terms:
|
Depression Depressive Disorder Depression, Postpartum Behavioral Symptoms Mood Disorders Mental Disorders Puerperal Disorders |
Pregnancy Complications Antidepressive Agents Psychotropic Drugs Central Nervous System Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on June 18, 2013